These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35836930)

  • 21. CD74 is a potential biomarker predicting the response to immune checkpoint blockade.
    Shi WQ; Chen DX; Du ZS; Liu CP; Zhai TT; Pan F; Chen HL; Liao WN; Wang SH; Fu JH; Qiu SQ; Wu ZY
    Cancer Cell Int; 2024 Oct; 24(1):340. PubMed ID: 39402601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.
    Hou Y; Zhang R; Zong J; Wang W; Zhou M; Yan Z; Li T; Gan W; Lv S; Zeng Z; Yang M
    Front Immunol; 2022; 13():892512. PubMed ID: 35711437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
    Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
    Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8
    Chen X; Xu R; He D; Zhang Y; Chen H; Zhu Y; Cheng Y; Liu R; Zhu R; Gong L; Xiao M; Wang Z; Deng L; Cao K
    Oncogene; 2021 Oct; 40(43):6223-6234. PubMed ID: 34552192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer.
    Ma Y; Zhan L; Yang J; Zhang J
    Front Pharmacol; 2022; 13():984555. PubMed ID: 36438826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules.
    Wang W; Dong D; Chen L; Wang H; Bi B; Liu T
    Front Genet; 2022; 13():893380. PubMed ID: 35937997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology.
    Liu Z; Xiang Y; Zheng Y; Kang X
    Front Immunol; 2022; 13():1027124. PubMed ID: 36341334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma.
    Yu X; Wang Z; Chen Y; Yin G; Liu J; Chen W; Zhu L; Xu W; Li X
    Front Genet; 2021; 12():771830. PubMed ID: 34721552
    [No Abstract]   [Full Text] [Related]  

  • 29. Integrated Analysis of Necroptosis-Related Genes for Prognosis, Immune Microenvironment Infiltration, and Drug Sensitivity in Colon Cancer.
    He R; Zhang M; He L; Huang J; Man C; Wang X; Lang Y; Fan Y
    Front Med (Lausanne); 2022; 9():845271. PubMed ID: 35479956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression.
    Du Y; Cao J; Jiang X; Cai X; Wang B; Wang Y; Wang X; Xue B
    Cancer Cell Int; 2021 Nov; 21(1):613. PubMed ID: 34801033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer.
    Wang H; Yin J; Hong Y; Ren A; Wang H; Li M; Zhao Q; Jiang C; Liu L
    Front Cell Dev Biol; 2021; 9():795133. PubMed ID: 35047505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling of Tumor Microenvironment Components Identifies Five Stroma-Related Genes with Prognostic Implications in Colorectal Cancer.
    Liu JW; Yu F; Tan YF; Huo JP; Liu Z; Wang XJ; Li JM
    Cancer Biother Radiopharm; 2022 Dec; 37(10):882-892. PubMed ID: 33085921
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.
    Sarfaty M; Golkaram M; Funt SA; Al-Ahmadie H; Kaplan S; Song F; Regazzi A; Makarov V; Kuo F; Ostrovnaya I; Seshan V; Zhao C; Greenbaum B; Liu L; Rosenberg JE; Chan TA
    J Clin Oncol; 2023 Jun; 41(17):3225-3235. PubMed ID: 36927002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
    Isaacs J; Anders C; McArthur H; Force J
    Curr Treat Options Oncol; 2021 Mar; 22(5):38. PubMed ID: 33743085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer.
    Ding Y; Ye Z; Ding B; Feng S; Zhang Y; Shen Y
    Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38856873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.
    Rong X; Lv J; Liu Y; Wang Z; Zeng D; Li Y; Li S; Wu J; Shen Z; Shi M; Liao W; Wu Z; Wang C
    Front Oncol; 2021; 11():802257. PubMed ID: 35155199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal tracing reveals diverse patterns of response to immune checkpoint blockade.
    Gu SS; Wang X; Hu X; Jiang P; Li Z; Traugh N; Bu X; Tang Q; Wang C; Zeng Z; Fu J; Meyer C; Zhang Y; Cejas P; Lim K; Wang J; Zhang W; Tokheim C; Sahu AD; Xing X; Kroger B; Ouyang Z; Long H; Freeman GJ; Brown M; Liu XS
    Genome Biol; 2020 Oct; 21(1):263. PubMed ID: 33059736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.